Advertisement
Advertisement

ACLX

ACLX logo

Arcellx, Inc. Common Stock

66.07
USD
-0.44
-0.66%
Jun 13, 15:59 UTC -4
Closed
exchange

After-Market

66.07

0.00
0.00%

Arcellx, Inc. Common Stock Profile

About

Arcellx Inc. is a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx Inc. is based in GAITHERSBURG, Md.

Info & Links

CEO

Rami Elghandour

Headquarters

800 BRIDGE PARKWAY
REDWOOD CITY, CA 94065, UNITED STATES

Sector

Medical

Auditor

PricewaterhouseCoopers LLP

Share holders

16

Employees

163

Arcellx, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

3.64B

Enterprise Value

3.56B

Enterprise Value/EBITDA(ttm)

-17.89

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

22.77

Price to Book(mrq)

7.30

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-25.94%

Profit Margin(ttm)

-318.28%

Return on Equity(ttm)

-8.28%

Return on Invested Capital(ttm)

-36.23%

Return on Assets(ttm)

-5.21%

Income Statement

Revenue(ttm)

76.81M

Revenue Per Share(ttm)

1.39

Gross Profit(ttm)

76.81M

EBITDA(ttm)3

-198.96M

Net Income Available to Common(ttm)

-162.42M

Diluted EPS(ttm)

-0.71

Share Statistics

Beta (5Y Monthly)

0.29

52-Week Change

21.43%

S&P 500 52-Week Change

9.20%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

55.11M

Dividend Yield

0.00%

Float4

50.70M

% Held by Insiders

6.24%

% Held by Institutions

96.03%

Balance Sheet

Total Cash(mrq)

543.47M

Total Cash Per Share(mrq)

9.86

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

4.93%

Quick Ratio(mrq)

4.29%

Book Value Per Share(mrq)

7.57

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.14

Free Cash Flow(ytd)

-63.92M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement